Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (7): 56-61.doi: 10.6040/j.issn.1671-7554.0.2024.0587
• 呼吸系统疾病精准诊疗专题 • Previous Articles Next Articles
CLC Number:
| [1] Hoenigl M, Seidel D, Sprute R, et al. COVID-19-associated fungal infections[J]. Nat Microbiol, 2022, 7(8): 1127-1140. [2] Abdoli A, Falahi S, Kenarkoohi A. COVID-19-associated opportunistic infections: a snapshot on the current reports[J]. Clin Ex Med, 2022, 22(3): 327-346. [3] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019(COVID-19)outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention[J]. JAMA, 2020, 323(13): 1239-1242. [4] Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance[J]. Lancet Infect Dis, 2021, 21(6): e149-e162. [5] Feys S, Lagrou K, Lauwers HM, et al. High burden of COVID-19-associated pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation[J]. Clin Infect Dis, 2024, 78(2): 361-370. [6] Apostolopoulou A, Esquer Garrigos Z, Vijayvargiya P, et al. Invasive pulmonary aspergillosis in patients with SARS-CoV-2 infection: a systematic review of the literature[J]. Diagnostics(Basel), 2020, 10(10): 807. doi: 10.3390/diagnostics10100807. [7] Arastehfar A, Carvalho A, van de Veerdonk FL, et al. COVID-19 associated pulmonary aspergillosis(CAPA)—from immunology to treatment[J]. J Fungi(Basel), 2020, 6(2): 91. doi: 10.3390/jof6020091. [8] Dellière S, Dudoignon E, Fodil S, et al. Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort[J]. Clin Microbiol Infect, 2021, 27(5): 790.e1-790.e5. [9] Salmanton-García J, Sprute R, Stemler J, et al. COVID-19-associated pulmonary aspergillosis, March-August 2020[J]. Emerg Infect Dis, 2021, 27(4):1077-1086. [10] Hashim Z, Nath A, Khan A, et al. Effect of glucocorticoids on the development of COVID-19-associated pulmonary aspergillosis: a meta-analysis of 21 studies and 5174 patients[J]. Mycoses, 2023, 66(11): 941-952. [11] Leistner R, Schroeter L, Adam T, et al. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients[J]. Crit Care, 2022, 26(1): 30. doi: 10.1186/s13054-022-03902-8. [12] WHO Rapid Evidence Appraisal for COVID-19 Therapies(REACT)Working Group, Sterne JAC, Murthy S, et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a Meta-analysis[J]. JAMA, 2020, 324(13): 1330-1341. [13] Alexander BD, Lamoth F, Heussel CP, et al. Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC/MSGERC[J]. Clin Infect Dis, 2021, 72(Suppl 2): S79-S88. [14] Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance[J]. Lancet Infect Dis, 2021, 21(6): e149-e162. [15] Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments[J]. Lancet Infect Dis, 2004, 4(12): 725-738. [16] Orenstein JM, Dieterich DT. The histopathology of 103 consecutive colonoscopy biopsies from 82 symptomatic patients with acquired immunodeficiency syndrome: original and look-back diagnoses[J]. Arch Pathol Lab Med, 2001, 125(8): 1042-1046. [17] He J, Liu Y, Wang Z, et al. Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation[J]. Chin Med J(Engl), 2008, 121(14): 1285-1289. [18] Wetwittayakhlang P, Rujeerapaiboon N, Wetwittayakhlung P, et al. Clinical features, endoscopic findings, and predictive factors for mortality in tissue-invasive gastrointestinal cytomegalovirus disease between immunocompetent and immunocompromised patients[J]. Gastroenterol Res Pract, 2021, 2021: 8886525. doi: 10.1155/2021/8886525. [19] Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13512. doi: 10.1111/ctr.13512. [20] Yeh PJ, Wu RC, Chen CL, et al. Cytomegalovirus diseases of the gastrointestinal tract in immunocompetent patients: a narrative review[J]. Viruses, 2024, 16(3): 346. doi: 10.3390/v16030346. [21] Kreitmann L, Helms J, Martin-Loeches I, et al. ICU-acquired infections in immunocompromised patients[J]. Intensive Care Med, 2024, 50(3): 332-349. [22] Gatto I, Biagioni E, Coloretti I, et al. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality[J]. Intensive Care Med, 2022, 48(6): 706-713. [23] Cevik M, Tate M, Lloyd O, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis[J]. Lancet Microbe, 2021, 2(1): e13-e22. [24] Lindahl AL, Ahava MJ, Haukipää M, et al. Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case report[J]. Infect Dis(Lond), 2023, 55(8): 585-589. [25] Chan M, Linn MMN, OHagan T, et al. Persistent SARS-CoV-2 PCR positivity despite anti-viral treatment in immunodeficient patients[J]. Lancet Infect Dis, 2023, 43(6): 1083-1092. [26] Machkovech HM, Hahn AM, Garonzik Wang J, et al. Persistent SARS-CoV-2 infection: significance and implications[J]. Lancet Infect Dis, 2024, 24(7): e453-e462. [27] 骆琼珍, 徐文帅, 高博, 等.新型冠状病毒感染患者核酸长期阳性的相关因素与核酸转阴的特点分析[J]. 中华医学杂志,2024, 104(5): 385-388. LUO Qiongzhen, XU Wenshuai, GAO Bo, et al. Analysis of the correlative factors of long-term positive nucleic acid and the characteristics of nucleic acid conversion in novel coronavirus infected patients[J]. National Medical Journal of China, 2024, 104(5): 385-388. [28] Peluso MJ, Deveau TM, Munter SE, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID[J]. J Clin Invest, 133(3): e163669. doi: 10.1172/JCI163669. |
| [1] | ZHANG Kun, ZHAGN Xiaoguo, CUI Xingxing, CHEN Shijun. Expression of apoptosis-related genes in peripheral blood mononuclear cells of patients with HBV infection and the relationship with chronicity of hepatitis B [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 38-42. |
| [2] | SENG Ming-hua， JIANG Hong-li， FENG Xiu-hong， GUO Yong-hao， ZHANG Xiao-xiao， GUO Wan-shen， FAN Jun-xing. Levels of the antibody to swine-origin influenza A(H1N1) virus in the population under 18 years in Henan Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(6): 155-. |
| [3] | CAO Aihua, DUAN Chunhong, QIU Bingping, LU Ling, LI Keliang, LIU Xuegong, ZHOU Zhiyuan, SUN Jianhua, JU Xiuli. Epidemiological and clinical characteristics of children infected with SARS-CoV-2 in Shandong Province [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 34-40. |
| [4] | . [J]. Journal of Shandong University (Health Sciences), 2020, 58(10): 134-136. |
| [5] | BAI Yao, CHEN Zhijun, SONG Shuxuan, HE Zhen, CHEN Baozhong, SHAO Zhongjun, LIU Kun. Investigation of a family cluster outbreak of coronavirus disease 2019 in Xian [J]. Journal of Shandong University (Health Sciences), 2020, 58(10): 95-99. |
| [6] | WANG Ling, CAO Haixia, ZHANG Ling, ZHANG Wenna, PAN Yanping, SHI Ying, ZHANG Wei, CUI Feng. Investigation and analysis of the characteristics of a family cluster of coronavirus disease 2019 in Zibo [J]. Journal of Shandong University (Health Sciences), 2020, 58(10): 100-104. |
| [7] | LI Xinrui, GENG Xingyi, WANG Weiru, ZHAO Xiaodong, LIU Lanzheng, ZHANG Xiaofei, LÜ Cuixia, CHANG Caiyun, LI Zhan, CUI Liangliang, RUAN Shiman. Consideration about cluster epidemic of 37 COVID-19 cases [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 32-40. |
| [8] | WANG Weiru, LI Xinrui, WANG Fang, ZHAO Xiaodong, YU Qiuyan, YANG Guoliang, LI Zhan, CHANG Caiyun, ZHAO Mengjiao, LIU Xiaoxue, LI Chuanbin, SUN Zhan, GENG Xingyi. Analysis of a family cluster outbreak of coronavirus disease 2019 in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 54-57. |
| [9] | ZHAO Mengjiao, LIU Zhong, LI Zhan, CHANG Caiyun, ZHAO Xiaodong, Geng Xingyi. Epidemiological investigation of a cluster associated with corona virus disease 2019 in Jinan City, China [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 44-48. |
| [10] | MA Yan, ZHANG Xiaoguo, ZHANG Zhongfa. Epidemiological analysis of 26 COVID-19 cases at a designated hospital in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 62-64. |
|
